Clinical Trial Detail

NCT ID NCT02476955
Title Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors ArQule
Indications

Advanced Solid Tumor

Therapies

ARQ092

Carboplatin + Paclitaxel

Age Groups: adult

No variant requirements are available.